Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Seminars in Dialysis|July 22, 2014
Evidence for the prevention and treatment of stroke in dialysis patientsWilliam Herrington, Richard Haynes, Natalie Staplin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2025
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney diseaseDoreen Zhu, Parminder K Judge, Natalie Staplin, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 12, 2014
The effect of the Pheroid delivery system on the in vitro metabolism and in vivo pharmacokinetics of artemisoneLizette Grobler, Anne Grobler, Richard Haynes, et al.
Future Healthcare Journal|July 21, 2021
Making trials part of good clinical care: lessons from the RECOVERY trialGuilherme Pessoa-Amorim, Mark Campbell, Lucy Fletcher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 28, 2019
Chronic kidney disease, heart failure and neprilysin inhibitionRichard Haynes, Doreen Zhu, Parminder K Judge, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 11, 2005
In vivo human Cartilage oligomeric matrix protein (COMP) promoter activityKaren L Posey, Sherri Davies, Elise S Bales, et al.
Trials|June 15, 2016
Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)Theingi Aung, Richard Haynes, Jill Barton, et al.
Lancet (London, England)|November 12, 2010
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial, Jane Armitage, Louise Bowman, et al.
American Heart Journal|April 15, 2018
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetesLouise Bowman, Marion Mafham, William Stevens, et al.
Lancet (London, England)|August 1, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Richard Haynes, Paul Harden, et al.
Pageof 13